z-logo
open-access-imgOpen Access
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study
Author(s) -
Antonio Ocampo,
Peré Domingo,
Pedro L. Fernández,
Julio Diz,
José Ramón Barberá,
Marcela Sepúlveda,
X Salgado,
Miguel Ángel Palomero Rodríguez,
Jesús Santos,
Miguel Yzusqui,
Marisa Mayorga,
Javier Fernández Lorenzo,
Alberto Bahamonde,
P Bachiller,
Elisa Martínez,
Nerea Rozas,
Carolina Machado Torres,
Álvaro Muñoz,
Araceli Casado,
Daniel Podzamczer
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky175
Subject(s) - tolerability , emtricitabine , rilpivirine , medicine , ritonavir , efavirenz , lamivudine , gastroenterology , prospective cohort study , cohort , viral load , human immunodeficiency virus (hiv) , adverse effect , antiretroviral therapy , virology , virus , chronic hepatitis
To analyse lipid changes and tolerability in a cohort of HIV-infected patients who switched their antiretroviral regimens to rilpivirine/emtricitabine/tenofovir (RPV/FTC/TDF) in a real-world setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom